“`html
PBMs Face Increased Scrutiny Over Drug Pricing Practices
Pharmacy Benefit Managers (PBMs), the frequently enough-hidden intermediaries in the prescription drug supply chain, are facing escalating scrutiny over their pricing practices and potential conflicts of interest. recent regulatory changes and legal challenges are aiming to increase transparency and possibly lower drug costs for employers and consumers. Federal officials estimate increased transparency could save employers and workers $1 billion
Keep reading